Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
British Journal of Anaesthesia|June 1, 1994
Prolonged decrease in heart rate variability after elective hip arthroplastyS C Marsch, K Skarvan, H G Schaefer, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Prevalence of functional iron deficiency in patients with malignancies and its impact on fatigue-specific quality of lifeS Zimmermann, S Aebi, O Gautschi, et al.
ESMO Real World Data and Digital Oncology|April 3, 2026
Corrigendum to "Prevalence of functional iron deficiency in patients with malignancies and its impact on fatigue-specific quality of life": ESMO Real World Data And Digital Oncology, volume 8 (2025), 100140S Zimmermann, S Aebi, O Gautschi, et al.
British Journal of Cancer|October 14, 2005
Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instabilityS L Smith, N L Bowers, D C Betticher, et al.
International Journal of Cancer|August 5, 2000
Bcl-xl antisense treatment induces apoptosis in breast carcinoma cellsA P Simões-Wüst, R A Olie, O Gautschi, et al.
International Journal of Cancer|May 8, 2000
Induction of apoptosis in lung-cancer cells following bcl-xL anti-sense treatmentS H Leech, R A Olie, O Gautschi, et al.
Respiration; International Review of Thoracic Diseases|January 25, 2014
Early detection of lung cancer: a statement from an expert panel of the Swiss university hospitals on lung cancer screeningT Frauenfelder, M A Puhan, R Lazor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 29, 2020
A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in SwitzerlandC M Panje, J E Lupatsch, M Barbier, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Patterns of progression on osimertinib in EGFR T790M positive NSCLC: A Swiss cohort studyS Schmid, D Klingbiel, S Aeppli, et al.
Pneumologie (Stuttgart, Germany)|November 9, 2018
[Strategies to Overcome Acquired Resistance to EGFR-TKI Therapy Based on T790M Specific Substances using Osimertinib as an Example]F Griesinger, S Radke, A Lüers, et al.
Pageof 5